Mycolic acid methyltransferase, MmaA4, is necessary for thiacetazone susceptibility in Mycobacterium tuberculosis
- 18 February 2009
- journal article
- Published by Wiley in Molecular Microbiology
- Vol. 71 (5) , 1263-1277
Abstract
Summary: Susceptibility of Mycobacterium tuberculosis to the second‐line antitubercular drug thiacetazone (TAC) requires activation by the monoxygenase, EthA. Here, we report isolation of spontaneous mutants in Mycobacterium bovis BCG that are highly resistant to TAC, but carry a functional EthA. Unexpectedly, a majority of the TAC‐resistant mutants lacked keto‐mycolic acids, which are long‐chain fatty acids associated with the cell wall and which contribute significantly to the physiopathology of tuberculosis. Predictably, causative mutations in the above mutants were in the gene encoding methyltransferase MmaA4, which is required for synthesis of keto‐ and methoxy‐mycolic acids. Drug‐resistant phenotype of the BCG mutants was reproduced in a mmaA4, but not in a mmaA3 null mutant of M. tuberculosis CDC1551. Susceptibility to TAC could be restored by complementation with a functional mmaA4 gene. Interestingly, overexpression of MmaA4 in M. bovis BCG made it more susceptible to TAC. We provide novel mechanistic insights into antitubercular drug activation by co‐ordinated actions of EthA and MmaA4. This study is the first demonstration of the participation of an enzyme linked to the synthesis of oxygenated mycolates in a drug activation process in M. tuberculosis, and highlights the interplay between mycolic acid synthesis, drug activation and mycobacterial virulence.Keywords
This publication has 38 references indexed in Scilit:
- Mycothiol biosynthesis is essential for ethionamide susceptibility in Mycobacterium tuberculosisMolecular Microbiology, 2008
- Mycolic Acid Modification by the mmaA4 Gene of M. tuberculosis Modulates IL-12 ProductionPLOS Pathogens, 2008
- Thiacetazone, an Antitubercular Drug that Inhibits Cyclopropanation of Cell Wall Mycolic Acids in MycobacteriaPLOS ONE, 2007
- EthA, a Common Activator of Thiocarbamide-Containing Drugs Acting on Different Mycobacterial TargetsAntimicrobial Agents and Chemotherapy, 2007
- Mechanism of thioamide drug action against tuberculosis and leprosyJournal of Experimental Medicine, 2007
- Trans-cyclopropanation of mycolic acids on trehalose dimycolate suppresses Mycobacterium tuberculosis-induced inflammation and virulenceJournal of Clinical Investigation, 2006
- Tracking the Putative Biosynthetic Precursors of Oxygenated Mycolates of Mycobacterium tuberculosisJournal of Biological Chemistry, 2003
- Activation of the Pro-drug Ethionamide Is Regulated in MycobacteriaJournal of Biological Chemistry, 2000
- Deciphering the biology of Mycobacterium tuberculosis from the complete genome sequenceNature, 1998
- Drug Treatment of Tuberculosis - 1992Drugs, 1992